Fundraising. Investor Relations. Advisory.

Hamza Thindal Capital Corp.

Hamza Thindal Capital provides fundraising, investor relations (IR) and capital markets advisory to emerging small-cap companies. Our success is based on a market oriented focus that aligns us with shareholders.

We offer a unique approach by having the ability to combine fundraising and investor relations expertise. The integration of these services provides our clients with a long term partner as their business grows.

Client News

May 15, 2013 iCo Therapeutics to Present at the Bloom Burton & Co. Healthcare Investor Conference

May 10, 2013 iCo Therapeutics to Raise $3.2 Million

May 08, 2013 Medicago successfully produces VLP vaccine candidate for H7N9 virus responsible for recent influenza outbreak in China

Market Indices

S&P/TSX Venture	1312.34	unch
S&P/TSX Composite	12613.05	+105.45
S&P/TSX Mid-Cap	860.14	+3.22
S&P/TSX Small-Cap	550.47	+0.87
NASDAQ	3462.61	+23.82